GO
Loading...

Pfizer Inc

More

  • Most active New York Stock Exchange-traded stocks Friday, 6 Mar 2015 | 1:26 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. fell 1.5 percent to $33.49 with 21,899,000 shares traded. AbbVie fell 1.5 percent to $56.00 with 11,825,100 shares traded.

  • Midday Glance: Pharmaceuticals companies Friday, 6 Mar 2015 | 1:25 PM ET

    Baxter International Inc. fell $1.02 or 1.5 percent, to $68.19. Bristol-Myers Squibb Co. fell$. 71 or 1.1 percent, to $65.34. Eli Lilly& Co. fell $1.31 or 1.9 percent, to $69.28.

  • Early Glance: Pharmaceuticals companies Friday, 6 Mar 2015 | 10:57 AM ET

    Baxter International Inc. fell$. 83 or 1.2 percent, to $68.38. Bristol-Myers Squibb Co. fell$. 35 or. 5 percent, to $65.70. Eli Lilly& Co. fell $1.21 or 1.7 percent, to $69.38.

  • *FDA set to decide on approval of Novartis' Zarxio. LONDON/ LOS ANGELES, March 6- A revolution is brewing in healthcare with lower-cost copies of complex biotech drugs finally set to reach the United States, nine years after so-called biosimilars were launched in Europe. The first approval for a biosimilar in the United States is expected imminently- Zarxio,...

  • Final Glance: Pharmaceuticals companies Thursday, 5 Mar 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 04 or. 1 percent, to $69.21. Bristol-Myers Squibb Co. rose$. 38 or. 6 percent, to $66.05. Eli Lilly& Co. fell$. 06 or. 1 percent, to $70.59.

  • Midday Glance: Pharmaceuticals companies Thursday, 5 Mar 2015 | 1:29 PM ET

    Baxter International Inc. fell$. 29 or. 4 percent, to $68.96. Eli Lilly& Co. fell$. 08 or. 1 percent, to $70.57. Hospira fell$. 08 or. 1 percent, to $87.87.

  • Early Glance: Pharmaceuticals companies Thursday, 5 Mar 2015 | 11:23 AM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $69.45. Bristol-Myers Squibb Co. rose $1.42 or 2.2 percent, to $67.09. Eli Lilly& Co. rose$. 27 or. 4 percent, to $70.92.

  • LONDON, March 5- AbbVie's $21 billion deal to buy Pharmacyclics shows big pharma's hunger for new drugs at a time when research at smaller biotechnology companies is driving some of the most promising advances in medicine. AbbVie's planned purchase of Pharmacyclics is the largest global pharmaceutical deal of 2015 to date and takes M&A activity in the sector...

  • March 5- AbbVie Inc is to buy Pharmacyclics Inc for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. AbbVie will pay $261.25 per share in cash and stock, a 13 percent premium to Pharmacyclics stock's closing price on Wednesday. Deutsche Bank analyst...

  • *AbbVie to pay $261.25 per share in cash and stock. The deal gives AbbVie access to Pharmacyclics' cancer drugs portfolio, lessening the Chicago- based company's dependence on its rheumatoid arthritis drug Humira that accounts for most of its sales. "Imbruvica is not only complementary to AbbVie's oncology pipeline, it has demonstrated strong clinical...

  • Final Glance: Pharmaceuticals companies Wednesday, 4 Mar 2015 | 6:17 PM ET

    Baxter International Inc. fell$. 17 or. 2 percent, to $69.25. Bristol-Myers Squibb Co. rose $3.75 or 6.1 percent, to $65.67. Eli Lilly& Co. rose$. 28 or. 4 percent, to $70.65.

  • Midday Glance: Pharmaceuticals companies Wednesday, 4 Mar 2015 | 1:16 PM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $69.53. Bristol-Myers Squibb Co. rose$. 86 or 1.4 percent, to $62.78. Eli Lilly& Co. rose$. 16 or. 2 percent, to $70.53.

  • Early Glance: Pharmaceuticals companies Wednesday, 4 Mar 2015 | 10:36 AM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $69.14. Bristol-Myers Squibb Co. fell$. 40 or. 6 percent, to $61.52. Eli Lilly& Co. fell$. 43 or. 6 percent, to $69.94.

  • Most active New York Stock Exchange-traded stocks Tuesday, 3 Mar 2015 | 6:05 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 7 percent to $34.41 with 19,173,400 shares traded. Bank of America Corp. rose. 2 percent to $16.04 with 64,587,000 shares traded.

  • Final Glance: Pharmaceuticals companies Tuesday, 3 Mar 2015 | 6:05 PM ET

    Baxter International Inc. fell$. 54 or. 8 percent, to $69.42. Bristol-Myers Squibb Co. fell$. 38 or. 6 percent, to $61.92. Eli Lilly& Co. fell$. 75 or 1.1 percent, to $70.37.

  • WASHINGTON— Fed Chair Janet Yellen may have gotten a job promotion last year, but her total assets don't appear to have gotten a bump. Her largest asset is a Vanguard Index Trust investment fund valued at between $1 million and $5 million that she owns with her husband. Yellen and her husband also own some individual stocks including ConocoPhillips, Raytheon,...

  • NEW YORK— Pfizer's blockbuster vaccine against pneumonia and other bacterial infections has won another approval, for use in European Union residents aged 18 and older. New York- based Pfizer says more than 750 million doses have been distributed worldwide. Last year, Prevnar's global sales reached $4.5 billion, making it the No. 2 product for the company, which...

  • Final Glance: Pharmaceuticals companies Monday, 2 Mar 2015 | 6:08 PM ET

    Baxter International Inc. rose$. 81 or 1.2 percent, to $69.96. Bristol-Myers Squibb Co. rose $1.38 or 2.3 percent, to $62.30. Eli Lilly& Co. rose$. 95 or 1.4 percent, to $71.12.

  • Early Glance: Pharmaceuticals companies Monday, 2 Mar 2015 | 11:16 AM ET

    Baxter International Inc. rose$. 34 or. 5 percent, to $69.49. Bristol-Myers Squibb Co. rose$. 81 or 1.3 percent, to $61.73. Eli Lilly& Co. rose$. 78 or 1.1 percent, to $70.95.

  • Hedge funds cut Apple and these other VIP stocks Monday, 2 Mar 2015 | 10:30 AM ET
    Workers prepare for the opening of an Apple store in Hangzhou, Zhejiang province, China, on Jan. 23, 2015.

    Many hedge funds sold down or exited positions in eight of the 10 most commonly held stocks, including Apple, Google and Exxon.